Douglas Karas - 09 Apr 2021 Form 4 Insider Report for Nascent Biotech Inc. (NBIO)

Role
Director
Signature
/s/ Douglas Karas
Issuer symbol
NBIO
Transactions as of
09 Apr 2021
Net transactions value
+$32,083
Form type
4
Filing time
20 Aug 2021, 09:48:02 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $23,333 +307,010 +42% $0.0760* 1,044,520 09 Apr 2021 Direct F1
transaction NBIO Common Stock Other $8,750 +83,334 +8% $0.1050* 1,127,854 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.